Come up with a name for your new list and we'll add to it:
Recursion Pharmaceuticals raised a round of funding on May 07, 2018. Investors include
Bill & Melinda Gates Foundation.
Recursion Pharmaceuticals leverages biological science, computation and artificial intelligence to provide a platform that discovers treatments for rare genetic disease and other conditions including …